AVEO Pharmaceuticals to present preclinical data from translational study platform at AACR 2010 AVEO Pharmaceuticals, Inc Get more information . , a biopharmaceutical company focused on discovering, commercializing and developing cancer therapeutics, today announced that preclinical data from its translational research system and antibody pipeline will become shown during six poster periods at the American Association for Cancers Analysis 101st Annual Meeting 2010 being kept April 17-21, 2010, in Washington, D.C. Robinson, Ph.D., senior vice president, translational medication, AVEO Pharmaceuticals. .
.. AUA: SGR is a fatally flawed payment system and a significant burden to physicians In response to today’s vote by Congress to legislation that provides a 10-month delay to Medicare physician reimbursement cuts, freezing current rates and averting a 27.4 % cut, the American Urological Association issued the following statement, due to AUA President Sushil S. Lacy, M.D., FACS: The SGR can be a fatally flawed payment system that has failed to keep pace with the expense of conducting business in this country. The SGR is usually a significant burden to physicians who struggle every year to keep their office doors open and provide ongoing quality treatment to seniors.